Real Time - berlex
Zeeshan: Chemical quota scam 2 CEOs’ remand extended
28 April 2012, 2:00 pm
Zeeshan
Chemical quota scam 2 CEOs’ remand extended
April 28
from The Nation News
- Comment
- Like
RAWALPINDI - Civil Judge Shafqat Ullah Saturday extended the physical remand of two chief executive officers (CEOs) of pharmaceutical companies in chemical quota scam for three days. Anti-Narcotics Force (ANF) staff produced Danas Pharmaceutical Islamabad’s CE Ansar Farooq and
berlex Lab International Multan’s CE Iftikhar Khan Babar before the court and pleaded for extending physical ... - Zeeshan
RAWALPINDI - Civil Judge Shafqat Ullah Saturday extended the physical remand of two chief executive officers (CEOs) of pharmaceutical companies in chemical quota scam for three days. Anti-Narcotics Force (ANF) staff produced Danas Pharmaceutical Islamabad’s CE Ansar Farooq and
berlex Lab International Multan’s CE Iftikhar Khan Babar before the court and pleaded for extending physical ... - Zeeshan
khabrain: Ephedrine case: Ali Musa records statement with ANF
26 April 2012, 6:29 am
khabrain
Ephedrine case: Ali Musa records statement with ANF - http://www.khabrain.info/ephedri...
April 26
from Khabrain
- Comment
- Like
ISLAMABAD:? While getting his statements recorded with the Anti-Narcotics Force (ANF) on Thursday in the Ephedrine case, Ali Musa Gilani, son of Prime Minister Yousaf Raza Gilani, said that three other Musas have been arrested in the case before and this time, too, someone had falsely claimed to be him. Ali Musa answered more than 550 questions asked by the ANF officials during a session that lasted about one hour 45 minutes. According to ANF sources, Ali Musa, during his testimony, said that he never met former director general health Dr Rasheed Jumma nor did he know him. He said that when the quota for ephedrine was being allotted to companies, he was out of the country for education and that ANF should launch a probe to find out who had been impersonating him. Meanwhile, an ANF court has rejected the plea for pre-arrest bails of Dr Jumma,
berlex Lab International Director Rizwan Khan and Danas Pharmaceutical Director Col (retd) Tahirul Wadood Lahoti had filed applications for... - khabrain
Zeeshan: 31,534-kg ephedrine quota given to 63 pharmas in 2010: Report
17 April 2012, 2:00 pm
Zeeshan
31,534-kg ephedrine quota given to 63 pharmas in 2010: Report
April 17
from The Nation News
- Comment
- Like
ISLAMABAD - The devolved Ministry of Health allocated a total quota of 31,534-kg ephedrine to 63 different pharmaceutical companies during 2010 whereas M/s
berlex Lab and Danas Pharmaceutical were issued quota of 9,000-kg out of the total one during the same year, reveals the investigations of Federal Investigation Agency (FIA) that were concluded in 2011.More interestingly, the inquiry report ... - Zeeshan
Patrick Damien: Yasmin Attorneys
14 April 2012, 6:48 am
Patrick Damien
Yasmin Attorneys - http://www.yasminlawsuitnews.com/yasmin-...
April 14
from delicious
- Comment
- Like
berlex and Bayer have known about the risk of potential Yasmin problems for some time and multiple studies have established the potential risk of life-threatening injuries. Despite the known risks, the drug makers have continued to market Yasmin without adequate warnings and introduced Yaz, another oral contraceptive containing drospirenone, which also carries the same risks. - Patrick Damien
Zeeshan: Only 90 out of 8500-kg ephedrine exported to Iraq
12 April 2012, 2:00 pm
Zeeshan
Only 90 out of 8500-kg ephedrine exported to Iraq
April 12
from The Nation News
- Comment
- Like
ISLAMABAD -
berlex Lab and Danas Pharmaceutical, the two pharmaceutical companies allegedly involved in the ephedrine drug scandal, had got total 8500-kg quota of ephedrine from the health ministry for a ‘fake’ export order as the chemical was never exported and consumed in the local market, an inquiry conduced by a key investigation agency in 2011 reveals.The ephedrine, that has ... - Zeeshan
Latest Android apps: myBETAapp™
29 November 2011, 5:50 pm
Latest Android apps
myBETAapp™ - http://www.appbrain.com/app...
November 29
from Get the Latest Android apps...
- Comment
- Like
myBETAapp™ is a personal injection reminder and tracker for your BETASERON® (interferon beta-1b) treatment, offered as part of the BETAPLUS® program. This app will help you to remember when and where to inject BETASERON and to keep a diary that you can share with your healthcare team. Read full description for Indications and Usage and IMPORTANT SAFETY INFORMATION along with additional features. For full Prescribing Information, please visit http://
berlex.bayerhealthcare.com/html... FEATURES • See today’s injection plan at a glance • See when and where your next injection is scheduled • View a monthly calendar of your injection schedule • See missed as well as scheduled injections • Customize which injection sites to include in your rotation schedule • Decide when and how to display a reminder alert for your next injection* • E-mail your injection history to yourself and your healthcare team† • Get easy access to the BETAPLUS patient support program online or... - Latest Android apps
Bayer emails discuss off-label uses for Yaz, Yasmin
21 November 2011, 11:05 am
Sector - Biotech/Pharma
Bayer emails discuss off-label uses for Yaz, Yasmin - http://www.fiercepharma.com/story...
November 21
from FiercePharma
- Comment
- Like
Note to pharma marketing pros: Avoid using the word "off-label" in your emails. As Bloomberg reports, some messages discussing potential off-label promotions for the birth control pills Yaz and Yasmin have found their way into a lawsuit over their safety. Some 10,000 suits allege Bayer downplayed risks of the drugs--which recently have been linked to a 74% increase in blood clots--while promoting them aggressively. Yaz is the subject of one set of emails obtained by Bloomberg, discussing the pill's potential as a PMS treatment. Approved as a therapy for severe PMS symptoms--premenstrual dysphoric disorder--Yaz could be used for garden-variety PMS, the emails suggest. Reps might use a woman's magazine article that supported that off-label use, one official at Bayer's
berlex Laboratories suggests. Another executive, reporting on a contract with women's health blogger and "Today" show contributor Dr. Judith Reichman, wrote, "[s]he definitely will mention the off-label benefits of our... - VCfeeds
